Analysis of the relapse of imported Plasmodium vivax and Plasmodium ovale in five provinces of China

Malaria Journal

Table 4 Comparison of factors influencing relapse or recrudescence of imported P. vivax and P. ovale from 2014 to 2021

Influencing factors	Relapse or recrudescence	Control group	Accounted for (%)	χ²	P-value
Drugs				35.737	< 0.001
a Artesunate for injection	15	29	34.09
a ACTs	29	83	25.89
a ACTs and artemisinins for injection	6	13	31.58
a, b Artemisinins and primaquine	3	20	13.04
b Chloroquine and artemisinins and primaquine	7	138	4.83
Different levels of medical institutions				75.319	< 0.001
c Self-treatment	23	5	82.14
d Outpatient clinic	10	69	12.66
d County-level medical institutions	16	123	11.51
d City-level medical institutions	17	65	20.73
d Provincial medical institutions	9	27	25.00
Any history of treatment abroad				1.038	0.308
Received treatment abroad	63	251	20.06
No treatment abroad	12	33	26.67

At the 0.05 level, there was no significant difference between group a, no significant difference between group b, and a significant difference between group a and b; no significant difference between group c, no significant difference between group d, and a significant difference between group c and d
Among the drug type factors, there were 15 cases without accurate medication records in the relapse or recrudescence group and 5 cases in the control group. Among the extraterritorial infection history factors, there were 5 cases with missing information in the control group

ISSN: 1475-2875